Author | Wei Z. Ai, MD | OncLive

Author | Wei Z. Ai, MD


Dr. Ai on the FDA Approval of Mogamulizumab in CTCL

August 08, 2018


Wei Z. Ai, MD, hematologist, University of California, San Francisco, discusses the FDA approval of mogamulizumab for the treatment of patients with cutaneous T-cell lymphoma who have received at least 1 prior systemic therapy.